NOX 0.00% 9.9¢ noxopharm limited

CEP is not a priority because DARRT and Lupin might be a more...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 872 Posts.
    lightbulb Created with Sketch. 8
    CEP is not a priority because DARRT and Lupin might be a more promising treatment based on current trials. Things change especially if you can get the result you are after. CEP never triggered an abscopal response. What if DARRT triggered an abscopal response?? Two out of 8 patients is already considered a very good result. My guess is DARRT did have some good results but not all of the patients did well hence the Lupin study. You dont do a Lupin phase 2 study if you dont know what is going on with the sponsored study. Remember the initial PSA response rate announced with LUPIN is really high.

    CEP will be used as paliative care so still has potential. The Advisary board will recommend what to do next. We will hear from them early next year.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.000(0.00%)
Mkt cap ! $29.22M
Open High Low Value Volume
10.0¢ 10.5¢ 9.9¢ $4.773K 48.10K

Buyers (Bids)

No. Vol. Price($)
1 20574 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 38542 2
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.